Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab()

SARS-CoV-2 is a new RNA virus which causes coronavirus disease 2019 (COVID-19), declared a pandemic by the World Health Organization (WHO). It triggers an atypical pneumonia that can progress to multiorgan failure. COVID-19 can cause dysregulation of the immune system, triggering an inflammatory res...

Descripción completa

Detalles Bibliográficos
Autores principales: Figuero-Pérez, Luis, Olivares-Hernández, Alejandro, Escala-Cornejo, Roberto A., Terán-Brage, Eduardo, López-Gutiérrez, Álvaro, Cruz-Hernández, Juan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561306/
https://www.ncbi.nlm.nih.gov/pubmed/34823820
http://dx.doi.org/10.1016/j.reumae.2020.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561306/
https://www.ncbi.nlm.nih.gov/pubmed/34823820
http://dx.doi.org/10.1016/j.reumae.2020.06.008

Ejemplares similares